328 related articles for article (PubMed ID: 28100513)
1. Loss of Ranbp2 in motoneurons causes disruption of nucleocytoplasmic and chemokine signaling, proteostasis of hnRNPH3 and Mmp28, and development of amyotrophic lateral sclerosis-like syndromes.
Cho KI; Yoon D; Qiu S; Danziger Z; Grill WM; Wetsel WC; Ferreira PA
Dis Model Mech; 2017 May; 10(5):559-579. PubMed ID: 28100513
[TBL] [Abstract][Full Text] [Related]
2. Microglial activation in an amyotrophic lateral sclerosis-like model caused by Ranbp2 loss and nucleocytoplasmic transport impairment in retinal ganglion neurons.
Cho KI; Yoon D; Yu M; Peachey NS; Ferreira PA
Cell Mol Life Sci; 2019 Sep; 76(17):3407-3432. PubMed ID: 30944974
[TBL] [Abstract][Full Text] [Related]
3. The coming-of-age of nucleocytoplasmic transport in motor neuron disease and neurodegeneration.
Ferreira PA
Cell Mol Life Sci; 2019 Jun; 76(12):2247-2273. PubMed ID: 30742233
[TBL] [Abstract][Full Text] [Related]
4. Impairments in age-dependent ubiquitin proteostasis and structural integrity of selective neurons by uncoupling Ran GTPase from the Ran-binding domain 3 of Ranbp2 and identification of novel mitochondrial isoforms of ubiquitin-conjugating enzyme E2I (ubc9) and Ranbp2.
Patil H; Yoon D; Bhowmick R; Cai Y; Cho KI; Ferreira PA
Small GTPases; 2019 Mar; 10(2):146-161. PubMed ID: 28877029
[TBL] [Abstract][Full Text] [Related]
5. Differential loss of prolyl isomerase or chaperone activity of Ran-binding protein 2 (Ranbp2) unveils distinct physiological roles of its cyclophilin domain in proteostasis.
Cho KI; Patil H; Senda E; Wang J; Yi H; Qiu S; Yoon D; Yu M; Orry A; Peachey NS; Ferreira PA
J Biol Chem; 2014 Feb; 289(8):4600-25. PubMed ID: 24403063
[TBL] [Abstract][Full Text] [Related]
6. Targeting the cyclophilin domain of Ran-binding protein 2 (Ranbp2) with novel small molecules to control the proteostasis of STAT3, hnRNPA2B1 and M-opsin.
Cho KI; Orry A; Park SE; Ferreira PA
ACS Chem Neurosci; 2015 Aug; 6(8):1476-85. PubMed ID: 26030368
[TBL] [Abstract][Full Text] [Related]
7. Proteostasis disturbance in amyotrophic lateral sclerosis.
Medinas DB; Valenzuela V; Hetz C
Hum Mol Genet; 2017 Oct; 26(R2):R91-R104. PubMed ID: 28977445
[TBL] [Abstract][Full Text] [Related]
8. Selective impairment of a subset of Ran-GTP-binding domains of ran-binding protein 2 (Ranbp2) suffices to recapitulate the degeneration of the retinal pigment epithelium (RPE) triggered by Ranbp2 ablation.
Patil H; Saha A; Senda E; Cho KI; Haque M; Yu M; Qiu S; Yoon D; Hao Y; Peachey NS; Ferreira PA
J Biol Chem; 2014 Oct; 289(43):29767-89. PubMed ID: 25187515
[TBL] [Abstract][Full Text] [Related]
9. The zinc finger cluster domain of RanBP2 is a specific docking site for the nuclear export factor, exportin-1.
Singh BB; Patel HH; Roepman R; Schick D; Ferreira PA
J Biol Chem; 1999 Dec; 274(52):37370-8. PubMed ID: 10601307
[TBL] [Abstract][Full Text] [Related]
10. Proteostatic Remodeling of Small Heat Shock Chaperones─Crystallins by Ran-Binding Protein 2─and the Peptidyl-Prolyl
Patil H; Yi H; Cho KI; Ferreira PA
ACS Chem Neurosci; 2024 May; 15(10):1967-1989. PubMed ID: 38657106
[TBL] [Abstract][Full Text] [Related]
11. Assay to Measure Nucleocytoplasmic Transport in Real Time within Motor Neuron-like NSC-34 Cells.
Shani T; Levy M; Israelson A
J Vis Exp; 2017 May; (123):. PubMed ID: 28570551
[TBL] [Abstract][Full Text] [Related]
12. Proteostatic remodeling of small heat shock chaperones - crystallins by Ran-binding protein 2 and the peptidyl-prolyl
Patil H; Cho KI; Ferreira PA
bioRxiv; 2024 Jan; ():. PubMed ID: 38352504
[TBL] [Abstract][Full Text] [Related]
13. Genomic organization, expression, and localization of murine Ran-binding protein 2 (RanBP2) gene.
Fauser S; Aslanukov A; Roepman R; Ferreira PA
Mamm Genome; 2001 Jun; 12(6):406-15. PubMed ID: 11353387
[TBL] [Abstract][Full Text] [Related]
14. Nuclear envelope localization of Ran-binding protein 2 and Ran-GTPase-activating protein 1 in psoriatic epidermal keratinocytes.
Yasuda K; Sugiura K; Takeichi T; Ogawa Y; Muro Y; Akiyama M
Exp Dermatol; 2014 Feb; 23(2):119-24. PubMed ID: 24438026
[TBL] [Abstract][Full Text] [Related]
15. Nucleocytoplasmic transport at the crossroads of proteostasis, neurodegeneration and neuroprotection.
Ferreira PA
FEBS Lett; 2023 Oct; 597(20):2567-2589. PubMed ID: 37597509
[TBL] [Abstract][Full Text] [Related]
16. Nucleocytoplasmic transport in C9orf72-mediated ALS/FTD.
Zhang K; Grima JC; Rothstein JD; Lloyd TE
Nucleus; 2016 Apr; 7(2):132-7. PubMed ID: 27116041
[TBL] [Abstract][Full Text] [Related]
17. The ER proteostasis network in ALS: Determining the differential motoneuron vulnerability.
Rozas P; Bargsted L; Martínez F; Hetz C; Medinas DB
Neurosci Lett; 2017 Jan; 636():9-15. PubMed ID: 27150076
[TBL] [Abstract][Full Text] [Related]
18. Neuroprotection resulting from insufficiency of RANBP2 is associated with the modulation of protein and lipid homeostasis of functionally diverse but linked pathways in response to oxidative stress.
Cho KI; Yi H; Tserentsoodol N; Searle K; Ferreira PA
Dis Model Mech; 2010; 3(9-10):595-604. PubMed ID: 20682751
[TBL] [Abstract][Full Text] [Related]
19. Mutant PFN1 causes ALS phenotypes and progressive motor neuron degeneration in mice by a gain of toxicity.
Yang C; Danielson EW; Qiao T; Metterville J; Brown RH; Landers JE; Xu Z
Proc Natl Acad Sci U S A; 2016 Oct; 113(41):E6209-E6218. PubMed ID: 27681617
[TBL] [Abstract][Full Text] [Related]
20. Altered nucleocytoplasmic proteome and transcriptome distributions in an in vitro model of amyotrophic lateral sclerosis.
Kim JE; Hong YH; Kim JY; Jeon GS; Jung JH; Yoon BN; Son SY; Lee KW; Kim JI; Sung JJ
PLoS One; 2017; 12(4):e0176462. PubMed ID: 28453527
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
